Reply to the “Inquiry Letter on Serious Abnormal Fluctuations in the Stock Trading of Chengdu Shengnuo Biotechnology Co., Ltd.”
Notice of Serious Unusual Fluctuations in Stock Trading
Minsheng Securities Co., Ltd.'s continuous supervision and follow-up report on the Chengdu Shengnuo Biotechnology Co., Ltd.'s 2024 semi-annual report.
Chengdu Shengnuo Biotechnology Co., Ltd. Investor Relations Activity Record Form 2024-03
Investor relations activity record of Chengdu Shengnuo Biotechnology Co., Ltd. 2024-02
Announcement Regarding the Holding of the 2024 Semi-Annual Performance Briefing.
Semi-annual evaluation report on the special action plan for quality improvement and efficiency increase of the company's return in 2024.
Announcement of the resolution of the 22nd meeting of the fourth board of directors.
Announcement of Resolutions of the 21st Meeting of the Fourth Supervisory Board.
Special report on the deposit and actual use of funds raised during the first half of 2024.
Announcement of Resolutions of the Twentieth Meeting of the Fourth Supervisory Board.
Verification opinion on the delay of certain investment projects funded by Chengdu Shenno Biotechnology Co., Ltd. by Minsheng Securities Co., Ltd.
Announcement Regarding Providing Patent Pledge and Joint Liability Guarantee for Subsidiary's Credit Application
Opinion on the verification of the pledge of patent rights and joint liability guarantee provided by Chengdu Shengnuo Biotechnology Co., Ltd., a subsidiary of Minsheng Securities Co., Ltd., for credit application.
Announcement of Resolutions of the Nineteenth Meeting of the Fourth Supervisory Committee.
Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Announcement of Resolutions of the 18th Meeting of the Fourth Board of Supervisors
Opinions of Minsheng Securities Co., Ltd. on the initial public offering of some restricted shares of Chengdu Shengnuo Biotechnology Co., Ltd. on the listing and circulation of some restricted shares
Notice on Voluntary Disclosure of Posaconazole Injections Obtaining Drug Registration Certificates
Minsheng Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Chengdu Shengnuo Biotechnology Co., Ltd.
No Data
No Data